📈 Stock Market 5h ago · Gerelyn Terzo

Medicare Negotiated Ozempic Down to $274 for 2027. Her Part D Plan Still Sets the Copay.

24/7 Wall St
View Channel →
Source ↗ 👁 0 💬 0
The post Medicare Negotiated Ozempic Down to $274 for 2027. Her Part D Plan Still Sets the Copay. appeared first on 24/7 Wall St..
A 68-year-old with type 2 diabetes sees the news flash and does the back-of-the-napkin math. The list price Medicare used for comparison was approximately $959 for a 30-day supply. Starting January 1, 2027, the published negotiated price for the semaglutide group that includes Ozempic is $274. She expects her pharmacy bill to fall by the same 71%. The balance may dro

Comments (0)

Sign in to join the discussion

More Like This

📰
FuelCell Energy Jumps 5%, Plug Power Climbs 4%, Bloom Energy Slips as the Hydrogen Trade Splits
24/7 Wall St. · 2h ago
Webull Is Having a Monster Quarter. Is BULL Stock Still a Buy?
24/7 Wall St. · 2h ago
📰
PIMCO’s Famous 16.5% Monthly Payer Always Cost 10% Extra. Right Now It’s Almost Free
24/7 Wall St. · 2h ago
📰
The Rise and Fall of America’s Tire Dynasty: Four Brands Bought by Foreign Giants and the One Titan Left
24/7 Wall St. · 2h ago
📰
Unusual Machines Jumps 7%, Ondas Climbs 4%, Kratos Defense Rises 3% as the Drone Trade Snaps Back
24/7 Wall St. · 2h ago
Could Netflix Stock Double From Here? The Numbers Are Getting Interesting.
24/7 Wall St. · 2h ago